Guggenheim Capital’s Lineage Cell Therapeutics LCTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q2 | – | Sell |
-37,290
| Closed | -$88K | – | 2502 |
|
|
2018
Q1 | $88K | Buy |
37,290
+3,323
| +10% | +$7.84K | ﹤0.01% | 2668 |
|
|
2017
Q4 | $63K | Sell |
33,967
-5,525
| -14% | -$10.2K | ﹤0.01% | 2626 |
|
|
2017
Q3 | $98K | Buy |
39,492
+1,788
| +5% | +$4.44K | ﹤0.01% | 2652 |
|
|
2017
Q2 | $103K | Buy |
37,704
+62
| +0.2% | +$169 | ﹤0.01% | 2694 |
|
|
2017
Q1 | $113K | Buy |
37,642
+83
| +0.2% | +$249 | ﹤0.01% | 2682 |
|
|
2016
Q4 | $119K | Buy |
37,559
+77
| +0.2% | +$244 | ﹤0.01% | 2754 |
|
|
2016
Q3 | $128K | Buy |
37,482
+9,339
| +33% | +$31.9K | ﹤0.01% | 2708 |
|
|
2016
Q2 | $64K | Buy |
28,143
+927
| +3% | +$2.11K | ﹤0.01% | 2767 |
|
|
2016
Q1 | $69K | Buy |
27,216
+4,771
| +21% | +$12.1K | ﹤0.01% | 2786 |
|
|
2015
Q4 | $74K | Buy |
22,445
+685
| +3% | +$2.26K | ﹤0.01% | 2864 |
|
|
2015
Q3 | $52K | Sell |
21,760
-636
| -3% | -$1.52K | ﹤0.01% | 2851 |
|
|
2015
Q2 | $65K | Sell |
22,396
-283
| -1% | -$821 | ﹤0.01% | 2938 |
|
|
2015
Q1 | $91K | Buy |
22,679
+3,275
| +17% | +$13.1K | ﹤0.01% | 2864 |
|
|
2014
Q4 | $58K | Buy |
19,404
+2,070
| +12% | +$6.19K | ﹤0.01% | 2896 |
|
|
2014
Q3 | $44K | Sell |
17,334
-13,954
| -45% | -$35.4K | ﹤0.01% | 2891 |
|
|
2014
Q2 | $77K | Sell |
31,288
-880
| -3% | -$2.17K | ﹤0.01% | 2989 |
|
|
2014
Q1 | $86K | Buy |
+32,168
| New | +$86K | ﹤0.01% | 2995 |
|
|
2013
Q3 | – | Sell |
-23,694
| Closed | -$76K | – | 3040 |
|
|
2013
Q2 | $76K | Buy |
+23,694
| New | +$76K | ﹤0.01% | 2774 |
|